763 related articles for article (PubMed ID: 26654192)
1. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.
Bachert C; Zhang L; Gevaert P
J Allergy Clin Immunol; 2015 Dec; 136(6):1431-1440. PubMed ID: 26654192
[TBL] [Abstract][Full Text] [Related]
2. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
[TBL] [Abstract][Full Text] [Related]
3. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
4. Biologics for chronic rhinosinusitis with nasal polyps.
Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
[TBL] [Abstract][Full Text] [Related]
5. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
[TBL] [Abstract][Full Text] [Related]
6. Atopy in chronic rhinosinusitis: impact on quality of life outcomes.
Ho J; Alvarado R; Rimmer J; Sewell WA; Harvey RJ
Int Forum Allergy Rhinol; 2019 May; 9(5):501-507. PubMed ID: 30604578
[TBL] [Abstract][Full Text] [Related]
7. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma.
Bachert C; Hellings PW; Mullol J; Naclerio RM; Chao J; Amin N; Grabher A; Swanson BN; Hamilton JD; Guillonneau S; Taniou C; Zhang D; Pirozzi G; Graham NMH; Staudinger H; Mannent LP; Khan A
J Allergy Clin Immunol Pract; 2019; 7(7):2447-2449.e2. PubMed ID: 30928658
[No Abstract] [Full Text] [Related]
9. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T
BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases].
Jandus P; Harr T; Soyka MB; Landis BN
Rev Med Suisse; 2019 Oct; 15(665):1748-1751. PubMed ID: 31580018
[TBL] [Abstract][Full Text] [Related]
11. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps.
Bachert C; Gevaert P; Hellings P
J Allergy Clin Immunol Pract; 2017; 5(6):1512-1516. PubMed ID: 28526278
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
Philpott CM; Erskine S; Hopkins C; Kumar N; Anari S; Kara N; Sunkaraneni S; Ray J; Clark A; Wilson A; ; Erskine S; Philpott C; Clark A; Hopkins C; Robertson A; Ahmed S; Kara N; Carrie S; Sunkaraneni V; Ray J; Anari S; Jervis P; Panesaar J; Farboud A; Kumar N; Cathcart R; Almeyda R; Khalil H; Prinsley P; Mansell N; Salam M; Hobson J; Woods J; Coombes E
Respir Res; 2018 Jun; 19(1):129. PubMed ID: 29945606
[TBL] [Abstract][Full Text] [Related]
13. Increased CXCL10 expression in nasal fibroblasts from patients with refractory chronic rhinosinusitis and asthma.
Yoshikawa M; Wada K; Yoshimura T; Asaka D; Okada N; Matsumoto K; Moriyama H
Allergol Int; 2013 Dec; 62(4):495-502. PubMed ID: 24153332
[TBL] [Abstract][Full Text] [Related]
14. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
Kariyawasam HH
Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
[No Abstract] [Full Text] [Related]
15. [Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
Boiko NV; Lodochkina OE; Kit MM; Kuleshova VG; Nedashkovskaya NG
Vestn Otorinolaringol; 2021; 86(2):43-48. PubMed ID: 33929151
[TBL] [Abstract][Full Text] [Related]
16. [Experience with dupilumab in the treatment of chronic rhinosinusitis with nasal polyps].
Boiko NV; Stagnieva IV; Lodochkina OE; Kurbatova NV
Vestn Otorinolaringol; 2023; 88(4):46-53. PubMed ID: 37767590
[TBL] [Abstract][Full Text] [Related]
17. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis.
Stevens WW; Peters AT; Tan BK; Klingler AI; Poposki JA; Hulse KE; Grammer LC; Welch KC; Smith SS; Conley DB; Kern RC; Schleimer RP; Kato A
J Allergy Clin Immunol Pract; 2019; 7(8):2812-2820.e3. PubMed ID: 31128376
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery.
Kim JE; Kountakis SE
Ear Nose Throat J; 2007 Jul; 86(7):396-9. PubMed ID: 17702319
[TBL] [Abstract][Full Text] [Related]
19. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
[TBL] [Abstract][Full Text] [Related]
20. African American Patients with Chronic Rhinosinusitis Have a Distinct Phenotype of Polyposis Associated with Increased Asthma Hospitalization.
Mahdavinia M; Benhammuda M; Codispoti CD; Tobin MC; Losavio PS; Mehta A; Jeffe JS; Bandi S; Peters AT; Stevens WW; Landay A; Keshavarzian A; Schleimer RP; Batra PS
J Allergy Clin Immunol Pract; 2016; 4(4):658-664.e1. PubMed ID: 26868728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
